These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 335702)

  • 21. The efficacy of calcifediol in renal osteodystrophy.
    Recker R; Schoenfeld P; Letteri J; Slatopolsky E; Goldsmith R; Brickman A
    Arch Intern Med; 1978 May; 138 Spec No():857-63. PubMed ID: 646574
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal osteodystrophy.
    Sherrard DJ
    Semin Nephrol; 1986 Mar; 6(1):56-67. PubMed ID: 3299577
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of vitamin D analogs in renal osteodystrophy.
    Johnson WJ
    Semin Nephrol; 1986 Mar; 6(1):31-41. PubMed ID: 3037668
    [No Abstract]   [Full Text] [Related]  

  • 24. [Renal osteodystrophy-II-Recent therapeutic acquisitions (author's transl)].
    Sebert JL; Fournier AE; Gueris J; Marie P; Coevoet B; de Fremont JF; Lambrey G; Kuntz D
    Nouv Presse Med; 1977 Nov; 6(38):3533-7. PubMed ID: 341079
    [No Abstract]   [Full Text] [Related]  

  • 25. Vitamin D today.
    DeLuca HF
    Dis Mon; 1975 Mar; ():1-37. PubMed ID: 165923
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of whole body and regional assessments of calcium balance in renal osteodystrophy in the response to 1 alpha-hydroxy vitamin D3.
    Naik RB; Robertson PW; Robinson BH; Dabek JT; James HM; Kanis JA
    Proc Eur Dial Transplant Assoc; 1977; 14():425-32. PubMed ID: 600960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of 1,25(OH)2-vitamin D3 to separate 'types' on renal osteodystrophy.
    Coburn JW; Brickman AS; Sherrard DJ; Singer FR; Wong EG; Baylink DJ; Norman AW
    Proc Eur Dial Transplant Assoc; 1977; 14():442-50. PubMed ID: 600961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status of diagnosis and treatment of renal osteodystrophy in the predialysis period.
    Lindenau K; Kokot F; Vetter K; Fröhling PT; Schmicker R; Futh U; Grossmann I
    Contrib Nephrol; 1988; 65():107-14. PubMed ID: 3168457
    [No Abstract]   [Full Text] [Related]  

  • 29. Nutrition and renal osteodystrophy.
    Morii H; Nishizawa Y; Miki T; Ohnishi Y; Okui Y; Song G; Yukioka K; Kikunami K; Matsushita Y; Inoue T
    J Nutr Sci Vitaminol (Tokyo); 1985 Dec; 31 Suppl():S67-9. PubMed ID: 3837819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of 1-alpha-hydroxyvitamin D 3 treatment of osteodystrophy in uremic patients treated with periodic hemodialysis].
    Palmieri P; Albertazzi A; Cappelli P; Di Paolo B
    G Clin Med; 1981 Jul; 62(7):443-60. PubMed ID: 7308629
    [No Abstract]   [Full Text] [Related]  

  • 31. [Letter: Onset stages of renal osteodystrophy. Study by quantitative biopsy in acute renal failure].
    Zech P; Meunier P; Beruard M; Edouard C; Pozet N; Traeger J
    Nouv Presse Med; 1973 Oct; 2(38):2551. PubMed ID: 4763460
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of 1 alpha-(OH)D3 on renal osteodystrophy--a 5-year retrospective evaluation].
    Kakuhara T; Mizoguchi M; Itoh M; Nagasawa M; Mori T; Ohtsuka K; Kubota M; Minatoguchi T; Ohara K; Yoshida M; Koide H; Ohno J
    Nihon Jinzo Gakkai Shi; 1982 Jun; 24(6):693-704. PubMed ID: 7176180
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of renal osteopathy].
    Binswanger U
    Schweiz Med Wochenschr; 1974 Jul; 104(27):965-7. PubMed ID: 4460235
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy.
    Martin KJ; Olgaard K; Coburn JW; Coen GM; Fukagawa M; Langman C; Malluche HH; McCarthy JT; Massry SG; Mehls O; Salusky IB; Silver JM; Smogorzewski MT; Slatopolsky EM; McCann L;
    Am J Kidney Dis; 2004 Mar; 43(3):558-65. PubMed ID: 14981615
    [No Abstract]   [Full Text] [Related]  

  • 35. Low-dose vitamin D analogues for renal osteodystrophy.
    Lancet; 1989 Jun; 1(8651):1364-5. PubMed ID: 2567378
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of renal osteodystrophy].
    Duursma SA; Dorhout Mees EJ
    Ned Tijdschr Geneeskd; 1978 Mar; 122(11):373-8. PubMed ID: 634388
    [No Abstract]   [Full Text] [Related]  

  • 37. Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed.
    Ferreira MA
    Nephrol Dial Transplant; 2000; 15 Suppl 5():8-14. PubMed ID: 11073268
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of uremic osteopathy. II. Effect of 5,6-trans-25-hydroxycholecalciferol in terminal kidney insufficiency].
    von Herrath D; Kraft D; Grigoleit HG; Schaefer K
    Dtsch Med Wochenschr; 1973 Jul; 98(28):1379-81. PubMed ID: 4197778
    [No Abstract]   [Full Text] [Related]  

  • 39. Osteodystrophy developing spontaneously in the course of chronic renal failure.
    Stanbury SW; Lumb GA; Mawer EB
    Arch Intern Med; 1969 Sep; 124(3):274-81. PubMed ID: 5806041
    [No Abstract]   [Full Text] [Related]  

  • 40. Recommendations for the treatment of renal osteodystrophy in dialysis patients.
    Slatopolsky E
    Kidney Int Suppl; 1975 Jan; (2):253-5. PubMed ID: 169423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.